Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6200.0000 88.00 (1.44%)
NSE Sep 19, 2025 15:31 PM
Volume: 735.0K
 

logo
Divi's Laboratories Ltd.
20 Nov 2020, 12:00AM
6200.00
1.44%
ICICI Securities Limited
Corporate earnings in Q2FY21 came in better-than-expected wherein companies benefitted from low raw material cost and realised operating leverage benefits with management commentary positive on pace of demand recovery and retaining some part of operating leverage gains in the post Covid world. At the index level, excluding the BFSI space; net sales fell ~10% YoY, primarily driven by double digit topline decline in the oil & gas space. On the profitability front, EBITDA margins at the index level came in at a multi-quarter high at 18.9%, up...
Divi's Laboratories Ltd. is trading above its 200 day SMA of 6120.8
More from Divi's Laboratories Ltd.
Recommended